Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06051695
Title A Study to Evaluate the Safety and Efficacy of A2B694, a Logic-gated CAR T, in Subjects With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression (EVEREST-2)
Acronym EVEREST-2
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors A2 Biotherapeutics Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
UCSD Moores Cancer Center RECRUITING La Jolla California 92093 United States Details
UCLA Medical Center RECRUITING Los Angeles California 90404 United States Details
Stanford University RECRUITING Stanford California 94305 United States Details
Mayo Clinic RECRUITING Jacksonville Florida 32224 United States Details
Moffitt Cancer Center NOT_YET_RECRUITING Tampa Florida 33606 United States Details
Massachusetts General Hopsital/Dana Farber Cancer Center RECRUITING Boston Massachusetts 02114 United States Details
Mayo Clinic Rochester RECRUITING Rochester Minnesota 55905 United States Details
Washington University RECRUITING St. Louis Missouri 63110 United States Details
NYU Langone Medical Center RECRUITING New York New York 10016 United States Details
Fred Hutchinson Cancer Center RECRUITING Seattle Washington 98109 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field